A detailed history of Black Rock Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Black Rock Inc. holds 5,565,071 shares of NVO stock, worth $753 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,565,071
Previous 7,297,919 23.74%
Holding current value
$753 Million
Previous $755 Million 5.35%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $177 Million - $236 Million
-1,732,848 Reduced 23.74%
5,565,071 $715 Million
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $66.2 Million - $79.6 Million
-754,387 Reduced 9.37%
7,297,919 $755 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $350 Million - $767 Million
3,843,987 Added 91.34%
8,052,306 $732 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $15.2 Million - $16.8 Million
-97,448 Reduced 2.26%
4,208,319 $681 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $42.1 Million - $50.7 Million
-318,398 Reduced 6.89%
4,305,767 $685 Million
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $8.32 Million - $11 Million
-81,101 Reduced 1.72%
4,624,165 $626 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $115 Million - $141 Million
1,205,180 Added 34.43%
4,705,266 $469 Million
Q2 2022

Aug 12, 2022

SELL
$103.24 - $121.81 $159 Million - $187 Million
-1,535,793 Reduced 30.5%
3,500,086 $390 Million
Q1 2022

May 12, 2022

BUY
$93.1 - $112.54 $146 Million - $177 Million
1,571,747 Added 45.37%
5,035,879 $559 Million
Q4 2021

Feb 10, 2022

BUY
$95.88 - $117.08 $4.4 Million - $5.37 Million
45,842 Added 1.34%
3,464,132 $388 Million
Q3 2021

Nov 09, 2021

BUY
$84.42 - $106.62 $21.2 Million - $26.7 Million
250,878 Added 7.92%
3,418,290 $328 Million
Q2 2021

Aug 11, 2021

BUY
$67.66 - $84.76 $214 Million - $268 Million
3,167,412 New
3,167,412 $265 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $305B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.